This trial is examining if setting the ventilator based on measurements of respiratory mechanics can help to reduce Day 60 mortality in patients with acute respiratory distress syndrome (ARDS), in both COVID-19 and non-COVID-19 patients.
1 Primary · 5 Secondary · Reporting Duration: Day 1-7, 14, 21, 28
Active Control
Experimental Treatment
740 Total Participants · 2 Treatment Groups
Primary Treatment: Respiratory Mechanics · No Placebo Group · N/A
Age 18+ · All Participants · 2 Total Inclusion Criteria
Mark “Yes” if the following statements are true for you: